Protagonist Therapeutics Inc buy BiotechBee
Start price
24.06.23
/
70%
€84.50
Target price
31.12.25
€40.00
Performance (%)
-
End price
31.08.23
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Protagonist Therapeutics Inc | -5.587% | -5.587% | 130.874% |
| iShares Core DAX® | 2.554% | -0.112% | 14.995% |
| iShares Nasdaq 100 | 2.742% | -0.470% | 30.954% |
| iShares Nikkei 225® | 6.584% | 3.221% | 49.697% |
| iShares S&P 500 | 1.930% | -0.519% | 24.883% |
According to BiotechBee what are the pros and cons of Protagonist Therapeutics Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Buy mit Kursziel 40,0
In the thread Trading Protagonist Therapeutics Inc
Buy beendet

